Word

H CUSABIO

Status

Pending

Status Code

661

Status Date

Wednesday, September 4, 2024

Serial Number

79382663

Mark Type

3

Filing Date

Friday, May 19, 2023

Trademark Owner History

WUHAN HUAMEI BIOTECH CO., LTD.

Classifications

5 Antibiotics for human use; Vaccines for human use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; enzyme preparations for medical purposes; pharmaceutical preparations, namely, antibody drugs for the treatment of cancer, tumors, anti-rejection of organ transplantation; pharmaceutical preparations for the treatment of tumors, cancer and infectious diseases, namely, antibodies, antibody derivatives, antibody-drug conjugates for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal drinks; chemical preparations for pharmaceutical purposes, namely, chemical reagents; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; dietetic substances adapted for medical use, namely, dietetic preparations, protein dietary supplements; antiseptics

1 Protein in raw material form for scientific and medical research; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; test paper, chemical; chemical reagents, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; diagnostic preparations, other than for medical or veterinary purposes; plant growth regulating preparations

10 Apparatus for artificial respiration; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; breath gas analyzers for medical diagnostics; medical diagnostic instruments for the analysis of body fluids; medical instruments for analysing and identifying bacteria; Medical apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing for medical purposes; dental apparatus, electric; galvanic therapeutic appliances; beds specially made for medical purposes; feeding bottles; orthopedic articles, namely, orthopedic braces; suture materials

42 Research and development of new products for others; technological research in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies, namely, conducting scientific project feasibility studies; conducting technical project studies in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies in the field of custom design and development of chemical reagents and biochemical assays; scientific laboratory services; cosmetic research; chemical analysis; chemistry services, namely, consultation in the field of chemistry, research and development services in the field of immunocytochemistry, chemical and biomolecular analysis, research in the fields of chemistry and biochemistry, chemical research laboratory services, consultancy in the field of biochemistry, research and development services in the field of biochemistry; chemical research; biological research; bacteriological research

Trademark Events

Feb 13, 2024

Assigned To Examiner

Feb 28, 2024

Non-Final Action Written

Mar 20, 2024

Non-Final Action Mailed - Refusal Sent To Ib

Mar 20, 2024

Refusal Processed By Mpu

Nov 9, 2023

Sn Assigned For Sect 66a Appl From Ib

Nov 13, 2023

New Application Office Supplied Data Entered

Nov 17, 2023

Application Filing Receipt Mailed

Feb 29, 2024

Non-Final Action (Ib Refusal) Prepared For Review

Jun 10, 2024

New Representative At Ib Received

Sep 4, 2024

Teas/Email Correspondence Entered

Sep 4, 2024

Correspondence Received In Law Office

Sep 4, 2024

Teas Response To Office Action Received

Apr 8, 2024

Refusal Processed By Ib